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Many neurodegenerative diseases exhibit axonal pathology, transport defects, and aberrant phosphorylation and aggregation of the
microtubule binding protein tau. While mutant tau protein in frontotemporal dementia and parkinsonism linked to chromosome 17
(FTDP17) causes aberrant microtubule binding and assembly of tau into filaments, the pathways leading to tau-mediated neurotoxicity
in Alzheimer’s disease and other neurodegenerative disorders in which tau protein is not genetically modified remain unknown. To test
the hypothesis that axonal transport defects alone can cause pathological abnormalities in tau protein and neurodegeneration in the
absence of mutant tau or amyloid deposits, we induced transport defects by deletion of the kinesin light chain 1 (KLC1) subunit of the
anterograde motor kinesin-1. We found that upon aging, early selective axonal transport defects in mice lacking the KLC1 protein
(KLC1/) led to axonopathies with cytoskeletal disorganization and abnormal cargo accumulation. In addition, increased c-jun
N-terminal stress kinase activation colocalized with aberrant tau in dystrophic axons. Surprisingly, swollen dystrophic axons exhibited
abnormal tau hyperphosphorylation and accumulation. Thus, directly interfering with axonal transport is sufficient to activate stress
kinase pathways initiating a biochemical cascade that drives normal tau protein into a pathological state found in a variety of neurode-
generative disorders including Alzheimer’s disease.
Introduction
Neurodegeneration associated with aberrant tau phosphoryla-
tion is coupled to the pathological destabilization of microtu-
bules, formation of intracellular paired helical filaments (PHF)
and neurofibrillary tangles (NFT) (Goedert and Spillantini, 2006;
Ballatore et al., 2007). In FTDP17, both loss and toxic gain of
function of mutant tau protein (Hutton et al., 1998; Spillantini et
al., 1998) result in a reduction of microtubule binding affinity
and increased assembly of tau into abnormal filaments (Na-
charaju et al., 1999; Barghorn et al., 2000). However, the initial
pathways that lead to tau-dependent neurotoxicity in Alzhei-
mer’s disease (AD), progressive supranuclear palsy, corticobasal
degeneration and other sporadic diseases are unknown. The
combined action of several kinases leads to tau phosphorylation
at 20 residues and in different subcellular compartments
(Hanger et al., 1998; Bue´e et al., 2000). Among these kinases,
axonal stress activated kinases can phosphorylate tau in vivo and
in vitro (Goedert et al., 1997; Reynolds et al., 1997; Chang et al.,
2003; Yoshida et al., 2004), and c-jun N-terminal stress kinase
(JNK) deposits that precede tau inclusions have been suggested to
be caused by early signaling deregulation events in the patholog-
ical cascade of cytoskeletal disorganization (Atzori et al., 2001;
Lagalwar et al., 2006). The possibility that axonal transport im-
pairments might induce the initiating events that lead to stress
kinase activation and tau pathology has been suggested by two
recent findings: (1) KLC1 reduction can exacerbate axonal pa-
thologies and amyloid  (A) plaque deposition in mouse mod-
els of AD generated by amyloid precursor protein (APP) overex-
pression (Stokin et al., 2005), and (2) axonal transport mediates
stress kinase signaling induced byneuronal damage (Cavalli et al.,
2005).
As a microtubule binding protein, tau is important for regu-
lating kinesin and dynein microtubule-based axonal transport of
cytoskeletal and synaptic cargos (Goldstein, 2003; De Vos et al.,
2008; Dixit et al., 2008). The anterograde motor complex
kinesin-1, formed by the association of two heavy chains and two
light chains, powers the transport of cargos such as APP, JNK
interacting proteins, and Alcadein to the synapse (Bowman et al.,
2000; Kamal et al., 2000; Verhey et al., 2001; Araki et al., 2007).
Not only is tau important formicrotubule-based transport which
in turn is essential for axonal and synaptic integrity, but also
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excess tau inhibits anterograde organelle and vesicular transport
in axons (Stamer et al., 2002). Furthermore, axonal protein accu-
mulation, neuritic swellings and white matter degeneration are
hallmarks of transport defects and abnormally phosphorylated
tau (Higuchi et al., 2002; McGowan et al., 2006; De Vos et al.,
2008). In AD and animalmodels of AD, phenotypes suggestive of
axonal transport defects occur early, before, and/or distant from,
sites of A deposition (Stokin et al., 2005). Such defects inmouse
and Drosophila are enhanced by reduction of kinesin-1 function
(Gunawardena andGoldstein, 2001; Stokin et al., 2005), andmay
be associatedwith accumulation of phosphorylated tau (Stokin et
al., 2005). Because increased APP gene dose can cause AD in
humans (Rovelet-Lecrux et al., 2006), and can also cause trans-
port defects inDrosophila andmouse that are independent of A
toxicity (Gunawardena and Goldstein, 2001; Stokin et al., 2008),
a key question is whether transport defects can cause aberrant tau
phosphorylation and conformation in the absence of A-
induced neurotoxicity. To test whether impaired axonal trans-
port is sufficient to cause tau-associated pathology, we analyzed
transport defects and neuronal pathologies in mice lacking the
KLC1 subunit of kinesin-1 (Rahman et al., 1999).
Materials andMethods
Mice. KLC1/ mice from a mixed 129/C57BL/6J background (Rah-
man et al., 1999)were backcrossed into pureC57BL/6J for 12 generations
and KLC1/ were crossed with each other to obtain wild type and
KLC1/. Genotyping was performed by PCR amplification of wild-
type and recombinant KLC1 alleles (Rahman et al., 1999).
Antibodies. The following monoclonal antibodies were used: MAP2
(Millipore Bioscience Research Reagents); p-NF (Sternberger Mono-
clonals); tubulin (Sigma); p-GSK3 (p-Y216),Drosophila Syntaxin (Hy-
bridoma Bank); -synuclein and JNK1/2 (BD Biosciences); and synap-
totagmin (Bellen). Polyclonal antibodies included APP, ubiquitin, and
ChAT (Millipore Bioscience Research Reagents); CDK5, phosphorylated
JNK (p-JNK), and P35 (Cell Signaling). We also used the following anti-
tau antibodies: TAU-5 (Biosource); AT-8 (Pierce); PHF13 (Covance);
and anti-p-tau:PHF1, CP13, TG3, and MC1 from P. Davies (Albert Ein-
stein College of Medicine, Bronx, NY).
Statistical analysis. Averages are plotted in each graph and error bars
represent the SEM. Asterisks indicate significance. For brain and spinal
cord stereology, nonparametric statistical test were used. As indicated,
one-way Kruskal–Wallis test or Mann–Whitney (two-sample rank sum)
was used to analyze total brain, corpus callosum, and spinal cord vol-
umes, and motor neuron counts. Student’s t test was used to determine
significance between KLC1/ and wild type in particle-tracking anal-
ysis and axonal frequencies and to compare fluorescent intensity levels in
quantitative Western blot analyses. Normal distribution was assayed for
each group, and a two-tailed Student’s t test was used. Smirnov–Kolmog-
orov test was used to analyze cumulative speed frequencies distribution
for app-yfp vesicles.
Primary hippocampal cultures. Newborn hippocampal brain regions
fromKLC1/ crosses were dissected on postnatal day 1. Treated inde-
pendently, hippocampiwere incubated in 0.22m-filteredmixture of 45
U of papain (Worthington) in PBS, DL-cysteine (Sigma), and BSA and
glucose (Sigma) enriched with 0.05% of DNase (BoehringerMannheim)
for 30 min at 37°C. Hippocampi were triturated by carefully pipetting in
10% FBS/DMEM. Cells were grown in 500 M L-glutamine and Neuro-
basal media supplemented with B27 (Invitrogen) over poly-D-lysine-
coated coverslips. pcdna3 CMV-APP-YFP (Kaether et al., 2000) contain-
ing a protein fusion between APP695 and yellow fluorescent protein
(YFP) was used for transfection between days 4 and 10. pcdna3 CMV-
MITO-EGFP (C. Vande Velde, University of California, San Diego, La
Jolla, CA) containing the enhanced green fluorescent protein (EGFP)
fused to a mitochondrial signal peptide from the human cytochrome C
was transfected after 4 d. Low transfection efficiency was obtained using
Lipofectamine 2000 (Invitrogen).
Movies and kymograph analysis. APP-YFP or MITO-EGFP movement
was registered in transfected primary cultures (Koo et al., 1990; Glater et
al., 2006) using an inverted epifluorescent microscope (TE-2000U, Ni-
kon) connected to a CoolSNAPHQ-cooled CCD camera (Roper Scien-
tific) and driven by MetaMorph 7.0 (Universal Imaging Corporation).
Cultures were kept under a 100 lens at 37°C using a heating stage and in
5% CO2 chamber (Harvard Apparatus). Sixteen to twenty-four hours
after transfection, cells were registered. Directionality was determined by
tracking axons far away fromcell bodies and imaging at theirmiddle part.
Particles moving from cell body to axon tips were considered antero-
grade and from tips to cell bodies retrograde. Continuous 15 s stacks (150
frames) at a speed of 100 ms were collected for APP-YFP (Kaether et al.,
2000). Time-lapse of 100 ms frames every 5 s for 10 min (120 frames)
were collected for MITO-EGFP (Glater et al., 2006). Kymographs were
plotted and average speed, distance, and directionality were extracted for
analyses.
Stereology. Stereologymeasurementswere obtainedwith a lightmicro-
scope Axioplan Zeiss associated with a Bioquant Nova image analysis
system (Bioquant R&M Biometrics). In brief, volume estimated from
brain and cervical cord were determined using 10 systematic random
serial sections of 50 m slices (Long et al., 1999; Mouton, 2002). Slices
were selected randomly together with another nine sections spaced apart
by 500 m (Long et al., 1999; Mouton, 2002). Cavalieri’s principle was
used for an unbiased estimation of an arbitrary shape volume.VCavalieri
t(A1 A2… Ap) (Mouton, 2002; Duerstock et al., 2003). Volumes
were obtained from the product of the distance between analyzed planes
(t) and the sum of registered areas on systematic-random sections (Sum
A) (Mouton, 2002). Motor neuron numbers were estimated using the
optical fractionator method, N  Q (1/ssf)(1/asf)(1/tsf). Random
serial sections were analyzed using Bioquant. Section sampling fraction
(ssf) is the number of sections sampled divided by the total number of
sections (10/100); area sampling fraction (asf) is the area of sampling
frame divided by the area of the x–y sampling step  1; and thickness
sampling fraction (tsf) is the height of the disector divided by the section
thickness  1. Criteria for profile counting required that cell bodies
exhibited positive ChAT immunoreactivity and morphological features
consistent with motor neurons. Axonal root numbers and diameters
were obtained from 1 M Epon sections of L5 lumbar roots stained with
toluidine blue using Bioquant. Cross-sectional area of each axon was
converted to diameter of a circle of equivalent area.
Protein quantification. Secondary fluorescent-labeled antibodies were
used inWestern blot analyses for quantification. SDS-PAGE protein gels
were transferred to nitrocellulose and blocked, and washes were per-
formed in the absence of Tween detergent to decrease background. Sec-
ondary antibodies coupled to 800 nm and 700 nm infrared fluorophore
were used in combination to detect levels of p-JNK and total JNK in the
samemembrane. Protein concentration curves were loaded and second-
ary antibodies used to detect respective antibodies affinities and to ob-
served linearity detection using this technique. Odyssey imaging system
scanner (Li-Cor) was used to measure fluorescence intensity.
Immunoelectron microscopy. Hippocampal and ventral regions of the
spinewere cut in several small pieces and processed for embedment in LR
White resin (Electron Microscopy Sciences). Ultrathin sections were in-
cubated with mab AT-8 (Pierce) (1:20) overnight at 4°C, incubated with
goat anti-mouse IgG conjugated to 6 nm gold (Aurion, ElectronMicros-
copy Sciences), and silver enhanced with Aurion R-Gent SE-EM (Elec-
tronMicroscopy Sciences). Sections were later stained with 2% ethanolic
uranyl acetate for 15min and lead citrate for 10min before observation in
the electron microscope.
Results
Early selective axonal transport defects induced by
KLC1 deletion
The neuronally enrichedKLC1motor subunit associates with the
force-generating kinesin heavy chain subunit to mediate the
transport of many vesicular and protein cargos (Rahman et al.,
1999). Although, it has been shown that APP depends on KLC1
for normal localization and processing in neurons (Stamer et al.,
2002; Stokin et al., 2005), it is not clear whether loss of KLC1 in
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early neuronal stages results in general im-
pairment of overall transport, or only in
selective defects within KLC1-dependent
pathways. To test how neuronal deletion
of KLC1 may impair transport we charac-
terized the axonal dynamics of two distinct
cargos with potentially different depen-
dencies upon KLC1. Cultured primary
hippocampal neurons from wild type and
KLC1/ showed similar polarization
and no obvious differences in neurite ex-
tension or branching (data not shown).
Polarizedmature neuronswere transiently
transfected with fluorescent fusion pro-
teins to compare the KLC1-dependent fast
axonal transport of APP vesicles (APP-
YFP) (Kaether et al., 2000; Kamal et al.,
2000), to the slower KLC1-independent
mitochondrial transport (MITO-EGFP)
(Hollenbeck and Saxton, 2005; Glater et
al., 2006) (Fig. 1a,g; supplemental Fig. 1,
available at www.jneurosci.org as supple-
mental material). Deletion of KLC1 in-
duced axonal transport defects of APP-
YFP vesicles, including a significant
decrease in the proportion of particles
moving in the anterograde direction (Fig.
1b), an increase in the number of retro-
grade particles (Fig. 1b), and a reduction in
net velocity and average run length for
anterograde and retrograde APP-YFP par-
ticles (Fig. 1c–f). In contrast, when we
evaluated the axonal movement of mito-
chondria in neurons transfected with
MITO-EGFP,we observed equivalent pro-
portions of anterograde, stationary, and
retrograde mitochondrial particles across
genotypes (Fig. 1h). Furthermore, veloci-
ties and run length of axonal anterograde
and retrograde mitochondria in
KLC1/ were comparable to those of
wild type (Fig. 1i,j). Thus, KLC1 deletion
does not impair hippocampal neuron devel-
opment and polarization, or mitochondrial
transport, in culture. However, loss of KLC1
causes early and selective axonal transport
defects of APP vesicles.
Age-dependent brain and spinal cord
axonopathies induced by KLC1 deletion
in mice
Axonal atrophy in the hippocampus and corpus callosum are
features of the neurodegenerative process affecting neuronal con-
nectivity in AD brains (Rose et al., 2000; Teipel et al., 2003; Xie et
al., 2006). Thus, given the proposed connections between axonal
transport defects and AD and to understand the consequences of
early selective axonal transport impairments in the mouse brain,
we characterized the age-dependent neuronal phenotypes in-
duced by KLC1 deletion. Initial examination of neuronal integ-
rity in KLC1/ mice revealed normal overall organization of
cortical layers and neuronal structures in young animals. How-
ever, as animals aged, axonal degeneration was observed in axon-
enriched structures (Fig. 2a,b) including the corpus callosum
(Fig. 2a,c) and the anterior commissure of the brain (data not
shown). Moreover,KLC1/ hippocampal regions had striking
axonal pathologies characterized by increased immunoreactivity
for phosphorylated neurofilaments (p-NF) in the dentate gyrus
and the CA1 region in 18-month-old mice (Fig. 2f).
Bielschowsky’s silver staining of swollen projections and spher-
oid structures in the CA3 region of aged KLC1/ brains (Fig.
2g) suggests the accumulation of argyrophilic materials within
degenerating axons.
Because prominent axonopathies with abnormal tau accumu-
lation and pronounced neuron degeneration are observed inmo-
tor neurons in transgenic mouse models of tauopathies (Ishihara
Figure 1. Early selective axonal transport defects in KLC1/ primary hippocampal neurons. a, Kymographs of APP-YFP
axonal transport from15 s (10Hz)movies (supplemental Fig. 1a, available atwww.jneurosci.org as supplementalmaterial). Right
or left descending particles equal anterograde or retrogrademoving vesicles, respectively. Vertical lines equal stationary particles.
Scale bar, 10 m. b, Average frequency of anterograde, stationary, and retrograde APP-YFP particles for WT (black) and
KLC1/ (white) (Student’s t test;WT, n 198 particles; KLC1/, n 285 particles; *p 0.05). Average net speed (c) and
run length (d) of APP-YFP anterograde and retrograde particles obtained from kymograph analyses (*p 0.05, **p 0.02).
Anterograde (e) and retrograde (f ) cumulative velocity distribution showing slower APP-YFPmovement velocities in KLC1/
(red) (Kolmogorov–Smirnoff distribution test; **p 0.02, ***p 0.0001). g, Kymographs of MITO-EGFP axonal transport
obtained from 600 s time-lapse movies (supplemental Fig. 1b, available at www.jneurosci.org as supplemental material). Scale
bar, 10m. h, Average frequency of anterograde, stationary, and retrogradeMITO-EGFP particles forWT (black) and KLC1/
(white). Average net speed (i) and run length (j) of anterograde and retrograde MITO-EGFP obtained from kymograph analyses.
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Figure 2. Axonopathies in the brain and spinal cord of KLC1/mice.a, Eighteen-month-oldwild-type (WT) and KLC1/ brain sections stainedwith thionin. Note reduction of axon bundles in the
corpus callosum (cc) in KLC1/ (hp, hippocampus; dg, dentate gyrus). Scale bar, 500m. b, Gray (gm) and white matter (wm) from a 12-slice montage of 18-month-old cervical spinal cord. Note wm
reductioninKLC1/.Scalebar,200m.c,d,WT(black)andKLC1/ (white)corpuscallosumandspinalcordvolumesestimatedusingCavalieri’sprinciple.c, ccvolumesfromyoungmice(Kruskal–Wallis
test;n3pergenotype, **p0.02).d, Total, gm, andwmvolumes from18-month-old spinal cords.e,Motorneuronnumber fromaged cervical spinal cordestimatedusing theoptical fractionatormethod
(Mann–Whitney test;n5per genotype, *p0.05, **p0.02, ***p0.002). f, Immunofluorescent staining of 18-month-old hippocampus for p-NF andnuclei (DAPI). Note abnormal accumulation of
p-NF within axonal swellings in KLC1/ (arrows) magnified from above insets. Scale bar, 50m. g, Bielschowlski’s silver stained argyrophilic cell bodies (arrow, top right), and spheroids and swellings
(arrowheads, left andbottomright)withinprojections inCA3 regionofKLC1/brain. Scalebars, 20m.h, i, ChAT immunohistochemistry in ventral horns (h) andmotor roots (i) fromcervical spinal cords.
Giantaxonaldystrophies(h,arrows)andswollenventralprojections(i,arrowheads)observedinKLC1/mice.Scalebar,20m. j,Frequencydistributionofaxonaldiameter inL5motorroots.Notereduction
of largecaliberaxonfrequencies inKLC1/ (Student’s t test;WT,n9;KLC1/,n10;*p0.05).k,Diameterdistributionofgiantaxonopathies inKLC1/ventralhorns. l, Frequencydistribution
of axonal diameter from cervical ventral roots ( 2 distribution test;WT,n 4; KLC1/,n 6; *p 0.05).
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et al., 1999; Spittaels et al., 1999; Lewis et al., 2000; Lin et al., 2005;
McGowan et al., 2006), we tested whether similar pathologies
were found in KLC1/ mice. Interestingly, a significant in-
crease in progressive age-dependent proximal swellings was ob-
served in KLC1/ cervical spinal cords at different ages (Fig.
3a). As in the brain, significant reductions in the white matter of
the spinal cord (Fig. 2b,d), and reduction of large caliber axons in
peripheralmotor roots (Fig. 2j) were observed in agedKLC1/
mice. The absence of p-NF accumulation in cell bodies suggests
that neurofilaments were delivered into axons before phosphor-
ylation and accumulation. Interestingly, two different types of
axonal pathologies were frequently seen in ventral regions of the
spinal cord after p-NF and APP staining in aged mice (Fig. 3b,c).
One type corresponds to giant axonal enlargements (dystro-
phies) showing average diameters of 60mand located proximal
to motor neuron cell bodies (Fig. 2h,k). The other type corre-
sponds to abnormal axonal swellings in ventral axonal roots of
the spinal cord with shifts in diameter distribution to distended
projections compared with wild type (Fig. 2i,l). Giant axonal
dystrophies and swollen ventral projections were also stained by
antibodies recognizing the motor neuron marker choline acetyl-
transferase (ChAT) (Fig. 2h,i) and together with the observed
motor neuron loss (Fig. 2e) suggest significant cholinergic degen-
eration in KLC1/ cervical spinal cord.
Organelle accumulation and cytoskeletal disorganization in
axonal swellings
Axonal microtubule destabilization and physical blockage of ax-
ons has been suggested to be part of the neurodegeneration
mechanism in tau-related diseases (Ballatore et al., 2007). Thus,
to test for cytoskeletal disorganization, and accumulation of ves-
icles and organelles similar to the axonal defects found in tauopa-
thies (Higuchi et al., 2002), we performed ultrastructural charac-
terization of axonal pathologies in 18-month-old KLC1/
Figure 3. Age-dependent increase of spinal cord axonal pathologies accumulating neurofilaments and APP. a, Confocal images showing staining for p-NF in ventral regions of the spinal cord in
wild type and KLC1/ at 6, 9, and 15month of age. Note increase in giant dystrophies (arrows) and swollen ventral projections (arrowheads) that accumulate p-NF immunoreactivity as animal
ages. Scale bar, 100m. b, Giant axonopathies (arrows) and swollen ventral projections (yellow arrowheads) showing the colocalization of p-NF and APP in 18-month-old KLC1/ spinal cord.
Note absence of p-NF staining in KLC1/ cell bodies (blue arrowheads). Scale bar, 50m. c, Magnifications from insets. Scale bar, 20m.
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mice. Hippocampal regions harbored swollen and distended ax-
ons containing disrupted microtubule networks, anomalous tu-
buloreticular structures, and atypical accumulations of mem-
brane stacks in distended neurites (Fig. 4a,c; supplemental Fig. 2,
available at www.jneurosci.org as supplemental material). Com-
parable accumulations with anomalous vesicle buildup were ob-
served in other distended projections of the hippocampus (Fig.
4b). In the spinal cord, ventral dystrophies were confirmed to be
axonal by the observation of a surrounding thin myelin sheet
(Fig. 4d,g; supplemental Fig. 2, available at www.jneurosci.org as
supplemental material). These giant dystrophies had massive
neurofilament accumulation with intermingled vesicles (Fig.
4e,f). Similarly, smaller and more abundant ultrastructural pa-
thologies were observed in swollen axons of ventral roots (Fig.
4h,i). Thus, deletion of the KLC1motor subunit causes early and
selective axonal transport deficiencies that compound in aged
KLC1/ animals to general transport impairments observed
as neuritic dystrophies, swellings, and axonal strangulation.
These physical obstacles may lead to accumulation of KLC1-
independent cargos such as mitochondria in aged mice (sup-
plemental Fig. 2e,f, available at www.jneurosci.org as supple-
mental material), causing axonal pathologies characterized by
microtubule disorganization and abnormal cytoskeletal and
organelle accumulations.
Aberrant tau behavior and
accumulation in
KLC1/ axonopathies
In AD, the pathological tau behavior starts
by synaptic and axonal tau protein hyper-
phosphorylation and microtubule desta-
bilization in dystrophic neurites (Su et al.,
1997). To test whether transport defects in
aged mice leads to abnormal axonal tau
phosphorylation and accumulation in
KLC1/ axonopathies, we performed
immunohistochemical staining using a
battery of tau antibodies in 18-month-old
mice. Abnormal axonal accumulations of
tau phosphorylated at Ser202 and Thr205
were observed by strong reactivity with the
AT-8 antibody in ventral giant axonal dys-
trophies and swollen axons along roots of
KLC1/ spinal cords (Fig. 5a). Similar
results were observed with another anti-
body against phosphorylated Ser 202
(CP13) (Fig. 5b), comparable to what is
observed in AD and in tauopathy models
(Goedert and Spillantini, 2006; McGowan
et al., 2006). However, no abnormal tau
was observed accumulating in neuronal
cell bodies. Two conformation specific an-
tibodies (TG3, MC1), also revealed strong
staining in giant axonal dystrophies and
swollenmotor roots (Fig. 5c,d), suggesting
that tau accumulation within those ax-
onopathies acquired a pathological con-
formation similar to that found in early
AD (Weaver et al., 2000). Equivalent ab-
normal tau behavior was observed with
staining for later tau phosphorylation
sites such as Ser396 and Ser404 (PHF1,
PHF13) (supplemental Fig. 3, available at
www.jneurosci.org as supplemental mate-
rial). ImmunoelectronmicroscopyusingAT-8confirmed the signif-
icant (more than threefold) abnormal density of hyperphosphory-
lated tau (Fig. 5g) within enlarged neurofilamentous structures of
KLC1/ giant dystrophies (Fig. 5e) and swollen roots (Fig. 5f)
compared with wild-type axons. Thus, transport defects induced by
KLC1deletion result in a local abnormal phosphorylation and accu-
mulation of tau in axons.
Increases in tau hyperphosphorylation have been suggested to
affect the aggregation of tau into the NFTs found in dystrophic
neurites (Ballatore et al., 2007). To test whether KLC1 transport
defects increased the soluble or the insoluble tau forms, we per-
formed cortex, brainstem, and spinal cord Sarkosyl extractions
from aged mice. Although overall levels of total (Tau-5) and
phosphorylated (PHF1, CP13) tau in homogenates ofKLC1/
were comparable to those in wild type, soluble levels of total and
phosphorylated tau were more abundant in KLC1/ brain-
stem and spinal cord, and total insoluble forms of tau in the
spinal cord were increased (supplemental Fig. 4b, available at
www.jneurosci.org as supplemental material). Large increases in
conformationally abnormal and hyperphosphorylated tau simi-
lar to those seen by immunohistochemistry were not observed.
However, considering the minimal tendency of mouse tau to
form abnormal filaments, and the focal nature of aberrant tau
accumulations in these mutant mice, it is not surprising that we
Figure 4. Cystoskeletal disorganization and organelle accumulation in brain and spinal cord axonopathies. a– c, KLC1/
hippocampal axonal swellings surrounded by myelin (arrowheads) are in c, loaded with membrane stacks and tubuloreticular
structures (arrows) observed among filamentous accumulations (asterisk). b, Vesicles, collapsed membranes and organelle
buildup (arrows) inside a CA3 axonal swelling. d–f, Giant axonal dystrophies surrounded by thin myelin layer (arrowheads) and
massive accumulation of dense neurofilament networks (asterisk) with intermingled vesicles (arrows). g–i, Ventral roots with
abundant axonal swellings accumulating similar dense filament (asterisk) and mitochondria (arrows). Scale bars: a, h, 1m; d,
10m; g, 5m; b, c, e, f, i, 100 nm.
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observed only modest overall increases in
soluble and insoluble tau relative to total
tau protein.
Transport defects induce abnormal
axonal stress kinase activation
Neurite stress or damage may induce the
activation of kinases implicated in abnor-
mal phosphorylation of tau and neurofila-
ments within dystrophic neurites (Goe-
dert et al., 1997; Reynolds et al., 1997;
Lagalwar et al., 2006). In addition, the di-
rect association of KLC1 and JNK interact-
ing scaffold proteins (JIP1, JIP2, and JIP3/
SYD) (Bowman et al., 2000; Verhey et al.,
2001) and the activation of JNK by axonal
damage (Cavalli et al., 2005) suggest that
transport defects could in principle lead to
aberrant phosphorylation of axonal pro-
teins. To evaluate whether JNK kinase ac-
tivation occurs in response to transport
defects in KLC1/ mice, we performed
quantitativeWestern blots from brain and
spinal cord homogenates using fluores-
cent secondary antibodies (Fig. 6a,b). We
observed a 75% increase in JNK activation
by p46 and p54 subunit phosphorylated at
Thr183 and Tyr185 in KLC1/ brain
homogenates compared with wild type
(Fig. 6c,d). No increasewas observed in the
activation of other tau-related kinases that
we tested (supplemental Fig. 4a, available
at www.jneurosci.org as supplementalma-
terial). To further test for abnormal axonal
stress kinase activation caused by selective
kinesin-1 transport impairments, we per-
formed immunofluorescent staining for
p-JNK. We observed a strong local activa-
tion of the axonal damage pathway as sug-
gested by selective p-JNK accumulation in
KLC1/ axonal pathologies (Fig. 6e).
Granular p-JNK staining colocalized with
p-NF diffuse accumulations in giant dys-
trophic axons and swollen motor roots (Fig. 6f). Elevated p-JNK
activation assessed by punctate staining was also found associated
with NFT in human AD (supplemental Fig. 5, available at www.
jneurosci.org as supplemental material); consistent with previous
observations in early stages of neurofibrillary pathology formation
(Pei et al., 2001; Lagalwar et al., 2006). We conclude that KLC1
deletion induces the abnormal activation of JNK within axonopa-
thies and that this aberrant kinase activity can generate abnormal
cytoskeletal tau phosphorylation.
Discussion
Microtubule disassembly induced by abnormal accumulation of
hyperphosphorylated tau protein and fibrillar aggregation of tau
into NFTs within axons are common pathologies in several neu-
rodegenerative dementias as well as movement disorders (Goe-
dert and Spillantini, 2006; Ballatore et al., 2007). Axonal trans-
port defects have been suggested as the ultimate cellular
mechanism impaired by tau protein loss of function and tau toxic
gain of function both in sporadic and familial tauopathies (Bal-
latore et al., 2007; Gasparini et al., 2007). However, the initial
events leading to tau misbehavior remain unknown. Together,
our results suggest the new hypothesis that impairments in ax-
onal transport can lead to aberrant behavior of tau protein simi-
lar to that observed in many neurodegenerative tauopathies.
Mutations in human kinesin and dynactin genes cause trans-
port defects and axonopathies that lead to different forms of
spastic paraplegia and amyotrophic lateral sclerosis respectively
(Goldstein, 2003; DeVos et al., 2008). It is interesting that deplet-
ing the KLC1 subunit of the kinesin-1 anterograde motor com-
plex induces early and selective impairments of APP bidirectional
movement, suggesting that kinesin-1 may be also involved in the
regulation of axonal retrograde transport. Initial transport de-
fects of KLC1-dependent cargos progress to general transport
impairments including microtubule disruption and mitochon-
drial accumulation in aged dystrophic axons. In addition, signif-
icant white matter reductions in aged mutant mice revealed that
axons became highly compromised upon KLC1 deletion. Inter-
estingly, selective KLC1 transport impairments uniquely induce
JNK stress kinase activation leading to abnormal tau behavior in
dystrophic axons. These results represent the first report where
Figure 5. Abnormal tau phosphorylation and accumulation in KLC1/ axonopathies. a–d, Eighteen-month-old WT and
KLC1/ immunohistochemistry showing tau hyperphosphorylation (AT-8, CP13; a, b) and conformationally abnormal tau
(TG3,MC1; c,d) accumulating in KLC1/ giant axonopathies (arrows, top) and in swollen ventral roots (arrowheads, bottom).
Scale bar, 10m. e, f, Immunoelectron microscopy of hyperphosphorylated tau (AT-8) showing accumulation of gold particles
(arrows) inside KLC1/ giant axonopathies (e) and swollen axons of ventral roots (f ). Scale bars: e, 200 nm; f, 1 m. g,
Average density quantification of immuno-gold particles/m2 fromWT (black) and KLC1/ (white) axonal roots (Student’s t
test; WT, n 10; KLC1/, n 16; ***p 0.006).
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deletion of a key motor protein subunit induces specific axonal
stress kinase pathways leading to the local abnormal phosphory-
lation and aggregation of tau. In this context, it is interesting that
human disorders involving axonal transport defects such as
amyotrophic lateral sclerosis with cognitive impairment exhibit
central and peripheral aggregated tau inclusion pathologies and
motor neuron death similar to those observed in aged KLC1
mutant mice. (Cairns et al., 2004; Strong et al., 2006; Mackenzie,
2007; Gohar et al., 2009).
Our suggestion that transport defects can initiate the genera-
tion of tau protein abnormalities is in agreement with the recent
findings showing that transport defects may be key early contrib-
utors to AD (Stokin et al., 2005). In fact, the realization that
excess APP can poison the transport machinery through an A-
independent mechanism (Gunawardena and Goldstein, 2001;
Stokin et al., 2008) raises the possibility that NFT initiation could
also be A-independent in some circumstances. In this regard, it
is striking that KLC1-deficient mice exhibit CNS white matter
degeneration, prominent axonal swellings with accumulation of
organelles, vesicles, and cytoskeletal components and abnormal
tau hyperphosphorylation comparable to those described in AD
(Rose et al., 2000; Higuchi et al., 2002; Xie et al., 2006). While the
spinal cord phenotypes we observed in KLC1-deficient mice are
not typical of CNS dementias such as AD, the pronounced age-
dependent accumulation of aberrant tau and neurofilaments
within spinal cord axonopathies andmotor neuron degeneration
are common features of transgenicmousemodels overexpressing
different forms of human tau (Ishihara et al., 1999; Spittaels et al.,
1999; Lewis et al., 2000; Probst et al., 2000; Lin et al., 2005). This
shared phenotype in mouse models may reflect species-specific
differences compared with humans, but nonetheless may reveal
conserved biochemical pathways induced by deficient axonal
transport that lead to common mechanisms of pathology and
disease development.
An additional hypothesis arising from our data point out that
impairments in transport can initiate damage signaling path-
ways, which if chronically activated, can trigger disease mecha-
nisms culminating in NFTs. Specifically, we found that KLC1
deletion induced early and selective transport defects of kinesin-1
cargos and increased activation of the axonal JNK stress kinase
pathway, a hallmark of axonal injury (Kenney and Kocsis, 1998;
Cavalli et al., 2005), andNFT formation inAD (Atzori et al., 2001;
Pei et al., 2001; Lagalwar et al., 2006). Thus, cytoskeletal disorga-
nization through JNK-mediated tau hyperphosphorylation
might auto-enhance by inducing additional and severe blockages
and swellings (Chang et al., 2003).
Figure 6. Increased JNK stress kinase activation in KLC1/ axonopathies. a, QuantitativeWestern blots ofWT brain homogenate using fluorescent secondary antibodies for JNK and p-JNK in
the samemembrane.b, Linear regression fit (R 2) of p46 fluorescence intensity by protein concentration for both JNK (green) and p-JNK (red)measurements. c, Western blots of 18-month-old total
brain homogenates using fluorescent secondary antibodies. Note specific increase in p46 and p54 JNK phosphorylation in KLC1/. d, Fluorescence intensity quantification of p46 subunit
phosphorylation inWesternblot analyses of brainhomogenates forWT (black) andKLC1/ (white).WTp-JNK/JNK ratiowas set to1 (Student’s t test;n6, **p0.02).e, f, Immunofluorescent
staining for p-NF and p-JNK in 18-month-old ventral spinal cord regions. Axonal dystrophies (arrows) and swollen projections (arrowheads) observed in KLC1/. Scale bar, 50m. f, Insets from
KLC1/ show colocalization of diffuse p-NF with punctate p-JNK staining in giant dystrophies (top) and swollen ventral projections (bottom). Scale bar, 10m.
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Together, our findings that reduction of kinesin-1 function
induces abnormal tau phosphorylation and conformation sug-
gest several important conclusions. First, transport defects in
neurons, in the absence of tau mutations or accumulation of A
or other neurotoxic agents, are sufficient to initiate biochemical
pathways that can culminate in pathological accumulation of tau.
Second, APP-induced transport defects may be capable of gener-
ating aberrant tau protein behavior in A-independent path-
ways. Third, the finding that kinesin-1 transport defects have
phenotypic effects comparable toAPP, presenilin, and tau (Gold-
stein, 2003; Stokin and Goldstein, 2006) suggest that these genes
affect common transport pathways that when altered can lead to
neurodegenerative diseases such as AD.
In light of these results, we propose a testable model in which
defects in axonal transport can lead to activation of axonal stress
kinase pathways, which increase the phosphorylation states of
cytoskeletal proteins such as tau and NF. If this activation is
chronic, human tau protein may ultimately form NFTs that fur-
ther impair axonal transport by disrupting the microtubule net-
work and blocking axonal highways, launching an autocatalytic
spiral culminating in neurodegeneration. Thus, early axonal
transport defects in AD and related tauopathiesmay share a com-
mon mechanism that ultimately will give rise to compromised
synapse function and neurodegeneration.
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